Email Updates

You are here

IMPAACT 2009 (DAIDS ID 30020)

Status
Planned
Phase
Demo Project
Objective

Parallel, observational cohort study of HIV-uninfected pregnant adolescents and young women (aged 16-24). The study is designed to characterize adherence over time among women who initiate once daily oral PrEP during pregnancy and continue in the first 6 months following delivery, and to compare pregnancy outcomes among women who take PrEP and women who decline PrEP during the antenatal period.

Prevention Option(s)
PrEP
Trial Sponsors
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network
Enrollment
350
16
Years
24
Years
Population
Women
Sites

Site(s) - Zimbabwe

Zimbabwe

Site(s) - Uganda

Uganda

Site(s) - South Africa

South Africa

Site(s) - Malawi

Malawi